Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 17, 2009

Endothelial Lipase Gene Mutations Result in High Levels of HDL-C

  • Mutations in the endothelial lipase gene (LIPG) result in high plasma HDL-C levels, according to scientists at the University of Pennsylvania. They determined that the increased plasma HDL-C levels are created because the mutations in LIPG cause loss of endothelial lipase activity.

    Therefore inhibition of endothelial lipase is likely to raise HDL-C levels in humans, the researchers suggest. They caution, however, that further study is required to find out whether the resulting increase would impact cardiovascular health.

    The authors examined LIPG in 585 subjects of European ancestry and identified 10 people with previously unreported rare mutated forms of this gene that were unique to subjects with very high HDL-C levels.

    The article appeared online March 16 in the Journal of Clinical Investigation.

Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »